.png "Jasvinder Singh, MD,MPH photo")
Baylor College of Medicine
Houston, TX, United States
Dr. Singh is a Professor of Medicine at the Baylor College of Medicine and a staff physician at the Michael E. DeBakey VA Medical Center at Houston, Texas. He is the past Director of the Gout Clinic at the University of Alabama Health Sciences Foundation. Dr. Singh’s research has focused on studies of outcomes in patients with rheumatic diseases, using large databases for conducting epidemiology and health services research, and performing interventional studies to improve outcomes in patients with rheumatic diseases. His current research is focused on conducting translational and clinical research in patients with gout, osteoarthritis, rheumatoid arthritis and lupus. Some of his studies focus on facilitating patient shared decision-making. His team is focused on patient-reported outcomes including quality of life, pain, and function in people with musculoskeletal diseases.
Cardiovascular Morbidity and Mortality in Gout Patients
Monday, October 27, 2025
8:30 AM - 9:00 AM Central Time
Disclosure(s): American College of Rheumatology: Consultant (Ongoing); ANI Pharma: Consultant (Terminated, October 31, 2022); Bluestar: Consultant (Ongoing); Clearview partners: Consultant (Ongoing); DINORA/Horizon: Consultant (Terminated, November 8, 2023); Frictionless solutions: Consultant (Ongoing); Fundacion Bechara: Consultant (Terminated, November 30, 2022); Gerson Lehrman: Consultant (Terminated, December 31, 2022); Hulio: Consultant (Ongoing); Inthough Research: Consultant (Ongoing); KeyQuest: Consultant (Terminated, June 30, 2022); Klick Inc: Consultant (Ongoing); Lucap: Consultant (Ongoing); Northwestern University: Consultant (Terminated, April 30, 2022); PCORI: Consultant (Ongoing); Schipher: Consultant (Terminated, June 30, 2022); Two labs: Consultant (Terminated, June 30, 2022); WebMD/Megfarage: Consultant (Ongoing); Wise: Consultant (Ongoing); Yale University: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 30, 2023)
Real-World Treatment Decisions in SLE: Can SLE Decision-Aid Help and Save Provider Time?
Tuesday, October 28, 2025
4:00 PM - 4:20 PM Central Time
Disclosure(s): American College of Rheumatology: Consultant (Ongoing); ANI Pharma: Consultant (Terminated, October 31, 2022); Bluestar: Consultant (Ongoing); Clearview partners: Consultant (Ongoing); DINORA/Horizon: Consultant (Terminated, November 8, 2023); Frictionless solutions: Consultant (Ongoing); Fundacion Bechara: Consultant (Terminated, November 30, 2022); Gerson Lehrman: Consultant (Terminated, December 31, 2022); Hulio: Consultant (Ongoing); Inthough Research: Consultant (Ongoing); KeyQuest: Consultant (Terminated, June 30, 2022); Klick Inc: Consultant (Ongoing); Lucap: Consultant (Ongoing); Northwestern University: Consultant (Terminated, April 30, 2022); PCORI: Consultant (Ongoing); Schipher: Consultant (Terminated, June 30, 2022); Two labs: Consultant (Terminated, June 30, 2022); WebMD/Megfarage: Consultant (Ongoing); Wise: Consultant (Ongoing); Yale University: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 30, 2023)
